Ba. Oyofo et al., Toxins and colonization factor antigens of enterotoxigenic Escherichia coli among residents of Jakarta, Indonesia, AM J TROP M, 65(2), 2001, pp. 120-124
Citations number
38
Categorie Soggetti
Envirnomentale Medicine & Public Health","Medical Research General Topics
Infection caused by enterotoxigenic Escherichia coli (ETEC) poses a serious
health problem among children and adults in developing countries. Coloniza
tion of the small intestinal mucosa by ETEC strains is mediated by antigeni
cally specific fimbriae, also known as colonization factor antigens (CFA).
The significance of this study arises from reports that active and passive
immunization with ETEC strains harboring CFAs has previously been shown to
induce protective immunity against diarrhea in animal models. The aim of th
is study was to determine toxin-associated CFAs of ETEC isolated from a dia
rrheal disease case-control study in Jakarta, Indonesia. Thirteen hundred a
nd twenty-three diarrheic and control patients with lactose-fermenting colo
nies were screened by ganglioside GM1-enzyme-linked immunosorbent assay (GM
1-ELISA) for heat-labile (LT) and heat-stable (ST) toxins. Two hundred and
forty-six (19%) ETEC isolates identified by GM1-ELISA for the LT/ST toxins
were screened for CFAs by Dot blot assay using monoclonal antibodies agains
t CFA/I, II, and IV and against the putative colonization antigens (PCF) PC
FO159, PCFO166, CS7, and CS17 Of the 246 ETEC isolates, 177 (72%) elaborate
d ST, 56 (23%) produced LT, while 13 (5%) elicited both the ST and LT toxin
s. CFA testing of the 246 ETEC isolates showed that 21 (8%) expressed CFA/I
, 3 (1%) exhibited CFA/II, 14 (6%) elaborated CFA/IV, while 7 (3%) expresse
d PCFO159 and PCFO159 plus CS5. No CFAs or PCFs could be associated with 20
1 (82%) of the ETEC strains. This report documents the types of CFAs associ
ated with ETEC strains in Jakarta, Indonesia. These data may help cur-rent
research efforts on the development of CFA-based vaccines for humans agains
t ETEC and provide additional information for future ETEC vaccine trials in
Southeast Asia.